Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07481019

A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology

The goal of this clinical trial is to evaluate whether an electronic patient-reported outcome measure (ePROM)-guided flexible scheduling system can improve outpatient clinic resource utilisation in patients attending dermatology outpatient clinics for routine follow-up. The main questions it aims to answer are:

* Does the intervention reduce the number of actualised outpatient visits over 12 months compared with standard fixed scheduling? * Does the intervention group achieve higher adherence to monthly ePROM monitoring, as measured by the proportion of completed ePROM submissions?

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Chronic Dermatological Conditions Acne Acne Vulgaris Acneiform Eruptions Dermatitis Eczema Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Psoriasis Sebaceous Gland Diseases Skin Diseases Skin Diseases, Eczematous Skin Diseases, Papulosquamous Skin Diseases, Vascular Skin and Connective Tissue Diseases Urticaria

Age range

16 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Dermatology outpatients otherwise due for a follow-up appointment within six months.
  • Ability to independently navigate and complete ePROMs.
  • Ability to provide informed consent (including parental consent for minors).

Exclusion criteria

  • Patients who require fixed or scheduled in-person visits, including those needing skin cancer surveillance, bedside procedures (e.g., liquid nitrogen therapy), surgical interventions, or routine blood tests for immunosuppressive therapy.

Treatment and study plan

Flexible ePROM-guided Scheduling System

Behavioral

Monthly ePROM responses will feed a Bayesian decision system to determine appointment need, which will then be used to make recommendations to patients for scheduling of appointments.

electronic patient reported outcome measures (ePROMs)

Behavioral

Monthly electronic patient reported outcome measures (ePROMs) surveys will be sent to patients' mobile devices to capture self-reported disease severity data.

Primary outcomes

  1. Number of actualised outpatient visits

    Time frame: baseline to week 52

    Difference in actualised outpatient visits (in-person + teleconsult) over 12 months (effectiveness outcome).

  2. Proportion of completed monthly ePROMs

    Time frame: baseline to week 52

    Difference in proportion of completed monthly ePROMs (implementation outcome)

Secondary outcomes

  1. No-show rate

    Time frame: baseline to week 52

    Number of appointments missed without prior rescheduling or cancellation

  2. Cancelled or rescheduled appointments

    Time frame: baseline to week 52

    Appointments booked but cancelled or rescheduled before the actual appointment date

  3. Urgent care or unscheduled visits

    Time frame: baseline to week 52

    Emergency department visits or other urgent care visits related to patient's dermatological condition

  4. Skin-specific Quality of Life Impairment

    Time frame: baseline, 6 months, 12 months

    Changes in quality of life using the Dermatology Life Quality Index (DLQI). Minimum Score: 0 (no impact on quality of life). Maximum Score: 30 (extremely large impact on quality of life).

  5. Clinician-assessed disease severity

    Time frame: baseline to week 52

    Clinician-assessed disease severity using body surface area and the investigator global assessment on a 0-5 NRS

  6. Acceptability of the intervention

    Time frame: week 52

    Assessed using the Theoretical Framework of Acceptability

  7. Perceived burden of engaging with the intervention

    Time frame: baseline, 6 months, 12 months

    Research questionnaire assessing perceived burden of intervention use

  8. Fidelity to the scheduling algorithm

    Time frame: baseline to week 52

    The extent to which algorithm-generated recommendations were followed, overridden, or superseded

  9. Barriers and facilitators to implementation

    Time frame: week 52

    Explored through semi-structured qualitative interviews

  10. Bayesian Decision-layer outputs

    Time frame: baseline to week 52

    Decision-layer outputs, including monthly posterior summaries and posterior predictive probabilities for each appointment category

Study contacts

Contact information is provided by the study sponsor or research team.

Ellie Choi, MBBS

CONTACT

[email protected]

65 6908 2222

Sponsors and collaborators

Lead sponsor

National University Hospital, Singapore

Other

Registry information

Important dates

Study start
2026
Primary completion
2029
Study completion
2029
First posted
Mar 18, 2026
Registry last updated
Jul 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.